缺血性卒中后癫痫发作的发病率与管理:系统综述与荟萃分析
关于药物治疗,未发现某种抗癫痫药物优于其他药物,但新型抗癫痫药物副作用较少。
要点
- 缺血性卒中后早期癫痫发作率为3.3%,晚期癫痫发病率为18/1000人年。
- 未发现特定抗癫痫药物在控制卒中后癫痫发作上优于其他药物。
- 新型抗癫痫药物与较少副作用相关。
核心结论
- 缺血性卒中相关癫痫发作和癫痫的负担 substantial。
- 需要进一步研究确定缺血性卒中后癫痫的危险因素和最佳二级预防。
研究设计与样本
- 系统综述与荟萃分析,纳入报告缺血性卒中后癫痫发作发病率或抗癫痫药物治疗反应的观察性研究。
- 大多数研究质量为低至中等。
主要发现
- 早期癫痫发作率为3.3%(95%CI 2.8%-3.9%,I2=92.8%)。
- 晚期癫痫发作或癫痫的发病率为每1000人年18例(95%CI 1.5-2.2,I2=94.1%)。
- 高异质性无法通过敏感性分析解释。
- 未发现任何单一抗癫痫药物比其他药物更有效,但新型抗癫痫药物与较少副作用相关。
临床怎么用
- 临床医生应意识到缺血性卒中后癫痫发作和癫痫的 substantial 负担。
- 选择抗癫痫药物时,可考虑新型药物因副作用较少,但疗效无显著差异。
局限性
- 大多数纳入研究质量为低至中等。
- 关于药物治疗的定性综合仅基于6项研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We conducted a meta-analysis of the incidence of early and late seizures following ischemic stroke as well as a systematic review of their pharmacologic treatment. METHODS: Observational studies that reported incidence of seizures following ischemic stroke and those that reported treatment response to any particular antiepileptic drugs (AEDs) were included. Risk of bias was assessed by predefined study characteristics. Random effects meta-analysis was conducted for all studies where data were available for the incidence of early and late stroke-related seizures. Heterogeneity was measured with I2 statistic and sensitivity analyses were performed using prespecified variables. A qualitative synthesis of studies reporting use of AEDs for stroke-related seizures was performed. RESULTS: Forty-one studies from 10,554 articles were identified; 35 studies reported incidence of stroke-related seizures and 6 studies reported effects of specific AEDs. Most studies were of low to moderate quality. Rate of early seizures was 3.3% (95% confidence interval 2.8%-3.9%, I2 = 92.8%), while the incidence of late seizures or epilepsy was 18 per 1,000 person-years (95% confidence interval 1.5-2.2, I2 = 94.1%). The high degree of heterogeneity could not be explained from the sensitivity analyses. For management of stroke-related seizures, no single AED was found to be more effective over others, though newer AEDs were associated with fewer side effects. CONCLUSIONS: The burden of stroke-related seizures and epilepsy due to ischemic stroke is substantial. Further studies are required to determine risk factors for epilepsy following ischemic stroke and optimal secondary prevention.
引用
- Wang JZ, Vyas MV, Saposnik G, et al. Incidence and management of seizures after ischemic stroke: Systematic review and meta-analysis. Neurology. 2017. PMID: 28835405. doi:10.1212/WNL.0000000000004407
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。